| scholarly article | Q13442814 |
| P2093 | author name string | McKechnie NM | |
| MacDonald MK | |||
| Duvall-Young J | |||
| P2860 | cites work | Ocular findings in systemic lupus erythematosus. | Q33996228 |
| Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study | Q36498419 | ||
| Immune-Complex Deposition in the Eye in Systemic Lupus Erythematosus | Q39901385 | ||
| Ocular immunopathology in murine lupus | Q40754740 | ||
| The immunopathophysiological effects of chronic serum sickness on rat choroid plexus, ciliary process and renal glomeruli | Q40790610 | ||
| Ocular Clinical Findings and Basement Membrane Changes in Goodpasture's Syndrome | Q43469847 | ||
| Toxemia of pregnancy. An angiographic interpretation of fundus changes | Q44273399 | ||
| RETINAL SEPARATION IN CHRONIC GLOMERULONEPHRITIS. REPORT OF A PATIENT CURED BY BILATERAL NEPHRECTOMIES AND SUBSEQUENT SUCCESSFUL KIDNEY TRANSPLANT. | Q46249265 | ||
| Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy | Q49229070 | ||
| Central Retinal Vein Occlusion Following Peritoneal Dialysis | Q54447352 | ||
| Characterization of mixed membranous and proliferative glomerulonephritis: recognition of three varieties | Q69370717 | ||
| The eye in malignant hypertension | Q69373353 | ||
| Corneal crystalline deposits and drusenosis associated with IgA-kappa chain monoclonal gammopathy | Q69948574 | ||
| Intraocular Pressure Changes During Hemodialysis | Q70600137 | ||
| Choroidal vascular changes in toxemia of pregnancy | Q71175478 | ||
| Ischemic infarcts of the choroid (Elschinig spots). A cause of retinal separation in hypertensive disease with renal insufficiency. A clinical and histopathologic study | Q72233669 | ||
| Retinopathies of chronic glomerulonephritis. A study of cases treated with renal transplantation | Q72752278 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glomerulonephritis | Q605006 |
| drusen | Q1140528 | ||
| P304 | page(s) | 297-302 | |
| P577 | publication date | 1989-04-01 | |
| P1433 | published in | British Journal of Ophthalmology | Q13443571 |
| P1476 | title | Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report | |
| P478 | volume | 73 |
| Q58739269 | A long history of dense deposit disease |
| Q37327009 | A microstructural retinal analysis of membrano-proliferative glomerulonephritis type II. |
| Q37822792 | Age-related macular degeneration: genetic and clinical findings |
| Q37994185 | Alport syndrome, basement membranes and collagen |
| Q27004686 | Animal models of age related macular degeneration |
| Q46510049 | Benign Yellow Dot Maculopathy: A New Macular Phenotype. |
| Q38616354 | Complement Activation and Inhibition in Retinal Diseases |
| Q33301870 | Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction |
| Q43905998 | Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: the Blue Mountains Eye Study |
| Q34574482 | Current concepts in C3 glomerulopathy |
| Q37286653 | Dense deposit disease and C3 glomerulopathy |
| Q46034637 | Dense deposit disease and the factor H H402 allele. |
| Q37304040 | Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities |
| Q39685560 | Flecked retina associated with ring 17 chromosome |
| Q52416047 | Foveal Densitometry in Adult-onset Diffuse Drusen |
| Q45883794 | Fundus changes in chronic membranoproliferative glomerulonephritis type II. |
| Q68038284 | Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients |
| Q33647566 | Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings |
| Q33647572 | Fundus changes in mesangiocapillary glomerulonephritis type II: vitreous fluorophotometry |
| Q53080314 | Fundus changes in type III membranoproliferative glomerulonephritis: a case report. |
| Q81230321 | Glycoproteins of drusen and drusen-like lesions |
| Q36804333 | Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration. |
| Q35449598 | High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2. |
| Q33953345 | Is renal function associated with early age-related macular degeneration? |
| Q33260025 | Macular degeneration: recent advances and therapeutic opportunities. |
| Q72542161 | Membranoproliferative glomerulonephritis type II associated with central serous retinopathy |
| Q37510769 | Multimodal imaging of membranoproliferative glomerulonephritis type II. |
| Q36860946 | New approaches to the treatment of dense deposit disease |
| Q51169833 | Ocular complications after kidney transplantation: a case report and review of literature. |
| Q38357009 | Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II. |
| Q46491539 | Optical coherence tomography of fundus findings in type II mesangiocapillary glomerulonephritis |
| Q26747262 | Overview of C3 Glomerulopathy |
| Q37285079 | Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. |
| Q34307036 | Photoreceptor topography in ageing and age-related maculopathy |
| Q67586507 | Posterior segment changes in membranoproliferative glomerulonephritis |
| Q37241305 | Posterior segment findings in a patient with immunotactoid glomerulonephritis |
| Q38088187 | Recent insights into C3 glomerulopathy |
| Q26741542 | Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN |
| Q55710477 | Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease. |
| Q33845185 | Retinal basement membrane abnormalities and the retinopathy of Alport syndrome |
| Q45064349 | Retinal changes associated with type 2 glomerulonephritis |
| Q47142300 | Retinal findings in membranoproliferative glomerulonephritis. |
| Q46445669 | Retinal function abnormalities in membranoproliferative glomerulonephritis type II. |
| Q67894558 | Sequential Observation of Fundus Changes in Patients with Long Standing Membranoproliferative Glomerulonephritis Type II (MPGN type II) |
| Q70153489 | Specific eye fundus lesions in type II membranoproliferative glomerulonephritis |
| Q36464283 | Spontaneous Resolution of Retinal Pigment Epithelial Detachments and Visual Improvement in Patient with MPGN II: A Case Report |
| Q43671971 | Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. |
| Q34289538 | Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. |
| Q30827994 | Symptomatic abnormalities of dark adaptation in patients with EFEMP1 retinal dystrophy (Malattia Leventinese/Doyne honeycomb retinal dystrophy). |
| Q52704996 | The amplification loop of the complement pathways. |
| Q34588115 | The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application |
| Q35985754 | Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5. |
| Q28191783 | Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease") |
| Q64039956 | [Patient with type II membranoproliferative glomerulonephritis: intravitreal bevacizumab therapy for choroidal neovascularization] |
Search more.